ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

April 25, 2014

Civin Moves From Hopkins To Maryland To Direct Stem Cell Medicine Center

January 9, 2009

ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials

December 31, 2010

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

In Brief: Yale Names DeVita Center Director; Canellos, Anrman Lead ASCO; Bresnick To Head AACR

June 4, 1993